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The Autism-Spectrum Quotient (AQ) is a self-report measure of autistic traits. It is frequently cited in diverse fields
and has been administered to adults of at least average intelligence with autism and to nonclinical controls, as well
as to clinical control groups such as those with schizophrenia, prosopagnosia, anorexia, and depression. However,
there has been no empirical systematic review of the AQ since its inception in 2001. The present study reports a
comprehensive systematic review of the literature to estimate a reliable mean AQ score in individuals without a
diagnosis of an autism spectrum condition (ASC), in order to establish a reference norm for future studies.
A systematic search of computerized databases was performed to identify studies that administered the AQ to
nonclinical participant samples representing the adult male and female general population. Inclusion was based on
a set of formalized criteria that evaluated the quality of the study, the usage of the AQ, and the population being
assessed.
After selection, 73 articles, detailing 6,934 nonclinical participants, as well as 1,963 matched clinical cases of ASC
(from available cohorts within each individual study), were analyzed. Mean AQ score for the nonclinical population
was 16.94 (95% CI 11.6, 20.0), while mean AQ score for the clinical population with ASC was found to be 35.19
(95% CI 27.6, 41.1). In addition, in the nonclinical population, a sex difference in autistic traits was found, although
no sex difference in AQ score was seen in the clinical ASC population.
These findings have implications for the study of autistic traits in the general population. Here, we confirm previous
norms with more rigorous data and for the first time establish average AQ scores based on a systematic review, for
populations of adult males and females with and without ASC. Finally, we advise future researchers to avoid risk of
bias by carefully considering the recruitment strategy for both clinical and nonclinical groups and to demonstrate
transparency by reporting recruitment methods for all participants.
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Autism was traditionally considered as a clinical condition
distinct from the general population, but recent evidence
suggests autistic traits are continuously distributed across
the population [1-3]. From observed data of measured aut-
istic traits, people with a diagnosis of an autism spectrum
condition (ASC) - at least those who have average IQ or
above - score at the extreme end of this distribution [4]. It
may be that ‘syndromic’ forms of autism, which often en-
tail comorbid learning disability (or below average IQ) and
a known genetic mutation, are discontinuous with autistic
traits in the general population, but here the focus is on
the general population without learning disability. The
Autism-Spectrum Quotient (AQ) is widely used in re-
search and clinical practice to quantify autistic traits. The
AQ was first developed as a self-report measure for adults
[5] and subsequently as a parent-report measure for ado-
lescents (aged 12 to 15 years) [6] and for children (aged 4
to 11 years) [7]. A toddler version also exists (Q-CHAT
(Quantitative Checklist for Autism in Toddlers) [8]). The
AQ has 50 items, which are divided into five subscales
consisting of 10 items each that assess domains of cog-
nitive strengths and difficulties related to ASC: commu-
nication, social skills, imagination, attention to detail
and attention switching. While the AQ is not the only
research tool used to measure autistic traits (for ex-
ample, see the SRS (Social Responsiveness Scale [9]), it
has several advantages over other measures, including
subscales for both social and nonsocial aspects of be-
havior and cognition and a format that is brief, self-
administered, and forced-choice.
The AQ was designed for adults with average IQ or
above [5], who comprise at least 50% of the autism
spectrum [10]. Individuals are instructed to respond to
each of the 50 items with one of four responses: ‘definitely
agree’, ‘slightly agree’, ‘slightly disagree’, and ‘definitely dis-
agree’. Responses are scored using a binary system, where
an endorsement of the autistic trait (either mildly or
strongly) is scored as a +1, while the opposite response is
scored as a 0, leading to a maximum score on the AQ of
50. An alternative scoring system has also been employed
that uses a 4-point Likert scale [11]. AQ items are coun-
terbalanced to avoid a response bias, so that half of the
‘agree’ responses and half of the ‘disagree’ responses en-
dorse the autistic trait. The AQ includes questions about
both ability and preference. The questionnaire is not
suitable for individuals with low IQ, low verbal ability, or
language impairment, as it relies on receptive understand-
ing of the 50 questions.
The AQ was originally validated in 2001 in adult males
and females with Asperger Syndrome (AS) and high-
functioning autism (HFA), in scientists versus nonscien-
tists in Cambridge University students, in winners of the
mathematical Olympiad (because of the finding thatautism may be genetically linked to an aptitude for
‘systemizing’ [12-14]), and nonstudent individuals drawn
from the general population. This study found that the
total AQ score and its five subscale scores are normally
distributed and have demonstrated good test-retest reli-
ability, good internal consistency [5], and that the meas-
ure has acceptably high sensitivity and specificity: at a
cut-off score of 26, 83% of patients were correctly identi-
fied (sensitivity 0.95, specificity 0.52, positive predictive
value 0.84, negative predictive value 0.78), while a cut-off
score of 32 correctly identifies 76% of patients (sensitivity
0.77, specificity 0.74) [11,15] when the AQ is used in a re-
ferred clinical sample.
These results indicate that the AQ is a sensitive meas-
ure of autistic traits in the general population, implying
that traits reaching a clinical level in autism also exist to
a lesser degree in nonclinical counterparts [5]. Within
families, AQ score has shown heritability, which is in
line with genetic evidence suggesting the heritability of
autism [16]. Further, some (but not all) parents of chil-
dren with autism show a subclinical set of characteristics
or traits that index familiarity and/or genetic liability to
autism [17,18]. This is referred to as the ‘Broader Autism
Phenotype’ (BAP). There is a consistent sex difference in
mean AQ score, such that typical males score signifi-
cantly higher than typical females, while people of both
sexes with ASC score at the extreme high end of the
scale, in line with the extreme male brain (EMB) theory
of autism [19,20].
The AQ is also widely referenced: a recent search of
Google Scholar indicated that the original publication has
been cited over 1,250 times. The present study reports the
first large-scale systematic review of published AQ data
over the last 13 years from adults with and without a diag-
nosis of ASC, in order to characterize the distribution of
autistic traits in adult males and females and to contrast
scores from clinical versus nonclinical samples. The spe-
cific goal is to establish a reliable mean AQ score in non-
clinical controls, which can then be used as a guideline for
researchers to define their control groups in future studies
that compare people with and without a clinical diagnosis
of ASC, as well as to other specially selected groups.
Review
Methods
Identification of relevant literature
Citation indexing databases Scopus, PubMed (Medline),
PsycINFO, and Web of Science were queried for articles
utilizing the AQ. Titles, abstracts and keywords were
searched for (“autism quotient”) OR (“autis* spectrum
quotient”) OR (“AQ” AND “autism”). Exploded MeSH
terms were not used because of the narrow target of
interest; studies were only considered if they explicitly
mentioned the AQ. However, an additional search of
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peer reviewed journal articles citing the 2001 Baron-
Cohen paper introducing the measure were retrieved.
The two searches were merged; the citation search de-
livered 837 hits and the keyword search delivered 321
hits, 287 of which were retrieved by both methods.
Titles and abstracts and then full text articles, were
reviewed. Inclusion criteria specified that the study had
to include peer-reviewed empirical research (excluding
all meta-analyses, literature reviews, book chapters, con-
ference proceedings, etcetera.), be published in English,
that the AQ had to be the 50-item AQ adult self-report
(and not the AQ-Child, AQ-Adolescent or any of the
abbreviated versions of the AQ), and that there was evi-
dence that the English-language version of the AQ had
been administered rather than any translations. The non-
clinical participant sample had to include both males andFigure 1 Selection process for systematic literature review: post-datafemales recruited from the population, with a mean age of
18 years or older.
Exclusion criteria were applied that assessed the qual-
ity of the study, the usage of the AQ, and the population
being assessed. See Figure 1 for the selection process.
Articles were excluded if they were case reports, studies
containing fewer than 10 participants, or if the study
specifically recruited participants who were immediate
family members of an individual with ASC or patients
with a particular mental or physical disorder or condi-
tion. In addition, due to findings from within the original
AQ publication indicating the potential for academic
disciplines to score more highly on the AQ, and in an
effort to remove confounding variables such as age and
education level, articles were excluded if participants
had been recruited exclusively from within a university
(though partial university recruitment was acceptable ifbase searches for English-language peer-reviewed research.
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from outside the academic community). Articles were
also excluded if an AQ cut-off score was imposed when
delineating the control or nonclinical group. Where it
was unclear whether an article met eligibility criteria,
the article was retained. A number of research groups
frequently recruit participants from the same database,
which may potentially lead to the same individuals’ AQ
scores being duplicated in analyses across more than
one publication; to guard against the risk of duplication,
articles from the same research group were assessed. If
authors used similar phrasing in describing the recruit-
ment process or explicitly stated that participants were
drawn from the same database, the publication with the
largest population group was included in analysis while
the rest were excluded. Finally, several articles published
in the same year by the same authors contained identical
AQ scores and numbers of participants; in these rare
cases, the earliest instance was included while the later
publications were conservatively excluded.
In a number of instances, authors indicated that par-
ticipants had completed the AQ but complete data sets
were not reported. For 36 papers, authors were con-
tacted for clarification or more information (11 articles
were lost due to lack of a response). The deadline for
data queries from authors and for literature searching
was Monday, 14 July 2014. From the literature search and
screening process 73 articles (reporting 78 independent
studies) met the inclusion criteria.
Inter-rater agreement
The first author (ER) performed 100% of the literature
search, quality assessment, and data extraction. In order
to assess reliability of this process, approximately 10% of
the results returned by the literature search were exam-
ined by authors CA, PS, and SBC. Each of the second
reviewers received a random sample of 30 articles for
evaluation (totaling 90). Where it was unclear whether
an article met eligibility criteria, the article was discussed
among the research team and if agreement was reached,
it was retained for inclusion in the analysis. Initial per-
centage inter-rater agreement was respectively 97%, 90%,
and 90%; after a resolution process, all disagreements
between the lead author and the second raters were re-
solved in favor of the first author.
Extraction of data from included papers
The following information was recorded:
1. Number of participants, delineated by sex if reported
2. Mean and standard deviation of AQ score for males,
females, and the sexes combined
3. Range of AQ score, if reported
4. Test for normality, if reported5. Mean and standard deviation of participants’ age
6. Recruitment strategy, if reported
7. A comment on whether the study excluded
individuals who were first-degree relatives of some-
one with a diagnosis of ASC
8. Margin of error and confidence intervals were
calculated for each study by ER
9. Mean AQ score was recorded if the study included a
matched sample of participants with ASC.
Data analysis
This systematic review aims to explore the distribution
of a single variable - AQ score - in a large nonclinical
population sample; therefore in this case, a meta-analysis
(for effect sizes) is not possible. Data were imported into
R [21] for systematic analysis. The mean of means was
calculated by differentially weighting the reported values
by sample size using weighted linear regression. In
addition, the range of standard distributions, along with
minimum and maximum values, was reported, and con-
fidence intervals for reported average AQ scores were
calculated. These values were also calculated for studies
reporting separate male and female AQ scores, which
were then compared using meta-analytic techniques.
Finally, a small subset of studies (N = 9) reported that, in
addition to taking a personal medical history, participants
were only eligible to be considered a part of the nonclini-
cal population group if they also had no first-degree rela-
tives with ASC. For these studies, a separate mean of
means for the AQ was also calculated. The focus of this
study concerned average performance on the AQ, but
standard deviation was also noted from eligible publica-
tions. From these scores, pooled variance was calculated.
While the primary focus of the review was to explore
AQ scores in a nonclinical population sample, AQ score
from the ASC sample for the selected papers was also
noted where relevant. These scores were analyzed in the
same method reported above. In addition to the quanti-
tative approach described above, the papers that met
criteria were subjected to a qualitative reading of the
recruitment strategy for the nonclinical participant sam-
ple. This was in an effort to provide a description of the
background for the participants included in analysis.
Results
Quantitative characterization of the Autism-Spectrum
Quotient in a nonclinical population sample
From a total of 73 articles reporting 78 studies that met
eligibility criteria, data were recorded from 6,934 individual
nonclinical participants. Table 1 describes the individual
studies reviewed. See also inset plot for study AQ means
and standard errors (Figure 2).
Descriptive statistics (weighted mean AQ, range of
standard deviation, total range, 95% confidence interval,
Table 1 Articles selected for review
Nonclinical sample Autism spectrum cases
Males Females Overall Range N
(Females)
Males Females Overall Range N
(Females)AQ m (SD) AQ m (SD) AQ m (SD)a AQ m (SD) AQ m (SD) AQ m (SD)a
[5] 17.8 (6.8) 15.4 (5.7) 16.4 (6.3) 174 (98) 35.1 (6.9) 38.1 (4.4) 35.8 (6.5) 58 (13)
[22] 15.9 (7.4) 16 (2) 37.5 (9.9) 16 (2)
[23] 15 (6) 6 to 30 20 (2) 38 (5) 28 to 46 21 (2)
[24] 14 (5.4) 6 to 26 22 (4) 38.5 (7.8) 16 to 49 22 (5)
[25] 16.65 (6.81) 24 (12) 34.63 (7.08) 16 (6)
[26] 16.5 (6.38) 30 (7) 33.93 (7.89) 30 (7)
[27] 14.9 (8.58) 21 (5) 37.1 (6.21) 21 (5)
[28] 11.6 (5) 12 (6) 36.7 (6) 12 (6)
[29] 12.53 (5.78) 18 (8) 35.28 (5.78) 18 (8)
[30] 14.64 (7.46) 28 (14) 34.93 (6.9) 28 (14)
[31] 17.33 (8.79) 2 to 42 22 (4) 35.86 (8.23) 17 to 48 21 (4)
[32] 18.81 (7.8) 17.21 (6.22) 35 (19)
[33] 15.3 (6.1) 12 (NA) 30.6 (9.7) 12 (NA)
[34] 14.86 (4.03) 24 (12)
[35] 13.13 (5.46) 6 to 29 23 (6) 34.39 (7.65) 21 to 46 23 (7)
[17] 17.7 (6.9) 13.1 (6.3) 988 (644)
[36] 14.12 (5.78) 127 (84)
[37] 15.8 (7.2) 19 (NA) 36.1 (8.7) 18 (NA)
[38] 19 (6.25) 12.15 (4.16) 15.13 (6.12) 23 (13)
[39] 14 (4.74) 17 (10)
[40] 15.8 (6.35) 19 (13)
[41] 16 (7) 2 to 33 91 (53)
[42] 19.64 (7.84) 15 (4) 37.06 (8.47) 16 (4)
[43] 16.72 (7.44) 18 (5)
[44] 19 (7.87) 17.36 (7.99) 2 to 45 838 (509) 37.8 (7.8) 39.8 (6.0) 8 to 50 449 (209)
[45] 15.4 (5.9) 19 (3) 27.6 (5.7) 14 (2)
[46] 13.7 (7.43) 32 (16) 36.9 (7.05) 29 (14)
[47] 13.7 (7.7) 30 (15) 36.8 (7.1) 28 (13)
[48] 11.7 (5.4) 10.4 (4.2) 53 (25) 28 (9.4) 31.9 (7.9) 50 (24)
[49] 15 (5.63) 13 (7) 31.82 (9.59) 14 (4)
[50] 13.67 (2.76) 18 (6) 34.39 (5.26) 18 (6)
[51] 14.05 (6.19) 3 to 29 38 (4)
[52] 14.61 (0.84) 35 (22)
[53] 13.8 (5.9) 16 (3)
[54] 14.1 (5.7) 96 (96)
[55] 16.5 (1) 32 (16)
[56] 14.55 (5.44) 29 (8)
[57] 19.1 (7.03) 706 (445)
18.6 (6.04) 452 (229)
[58] 16.8 (7.6) 7 to 33 16 (12)
[59] 11.9 (4.5) 3 to 21 32 (3) 29.4 (7) 16 to 44 32 (2)
[60] 15.1 (5.8) 5 to 28 47 (18) 35.8 (5.9) 22 to 46 38 (38)
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[61] 14.05 (5.8) 129 (83) 36.04 (7.13) 104 (46)
[62] 16.4 (6.11) 15 (9) 29.44 (8.6) 13 (4)
[63] 17.88 (8.21) 16 (4) 33.13 (10.09) 16 (1)
[64] 13.72 (5.67) 18 (5) 34.67 (6.89) 18 (5)
[65] 19 (7.1) 600 (383)
[66] 13.6 (7.86) 4 to 37 25 (25) 36.6 (6.53) 22 to 49 25 (4)
[67] 16.69 (5.69) 7 to 31 36 (18)
[68] 14.86 (6.22) 3 to 37 216 (NA)
[69] 16.3 (7.7) 342 (79) 35.32 (7.69) 223 (155)
[70] 15.6 (6.9) 12 (4.8) 60 (30) 32.7 (7.3) 37.5 (6.7) 60 (30)
[71] 12.11 (5.03) 28 (7) 34.15 (8.61) 27 (6)
[72] 16 (5.1) 5 to 28 67 (52)
[73] 13 (5) 18 (6) 34 (10) 18 (9)
[74] 18.1 (7.5) 228 (149) 36 (7.6) 209 (122)
[75] 15.6 (6) 18 (12)
[76] 14.6 (5) 18 (2) 30.4 (4.6) 16 (3)
[77] 13.09 (5.79) 22 (13)
[78] 20 (9.7) 119 (60) 36.4 (7.3) 70 (30)
[79] 13.03 (5.85) 2 to 26 31 (17)
[80] 17 (7) 5 to 33 15 (10)
[81] 17.41 (6.89) 163 (91)
[82] 13.2 (6.1) 31 (3) 29.5 (7.5) 39 (3)
[83] 18.26 (4.49) 16.95 (4.67) 17.61 (4.57) 38 (19)
[84] 12.52 (5.41) 29 (7) 34.44 (8.78) 27 (6)
[85] 12.26 (5.45) 3 to 21 19 (4) 35.16 (7.59) 21 to 45 19 (4)
[86] 13.8 (5.7) 17 (6) 37.3 (9.9) 14 (7)
[87] 19.57 (7.48) 134 (NA)
[88] 15.65 (1.59) 20 (10)
16.5 (1.26) 20 (10)
18.45 (1.48) 20 (10)
15.15 (0.83) 26 (13)
15.85 (1.26) 26 (13)
[89] 11.43 (4.2) 14.2 (4.5) 12.58 (4.36) 7 to 20 12 (5) 40.13 (6.77) 42.5 (4.42) 41.14 (5.8) 14 (6)
[90] 15 (6) 14 (5) 29 (16) 38 (13) 39 (13) 30 (16)
[91] 17.2 (5.2) 12 (4)
[92] 15.24 (6.37) 17 (3) 35.59 (9.17) 17 (3)
Studies ordered chronologically; blank cells indicate data not reported (or for patients, AQ not administered to individuals with an autism spectrum condition).
Overall AQ meana refers to combined male and female score.
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uals) are shown in Table 2. Overall SD reported from
included studies ranged from 0.83-9.7. A pooled variance
was calculated from the scores (σ2 = 31.26), leading to a
pooled standard deviation of 5.59.
To compare the weighted mean AQ scores between
males and females in studies that reported this informa-
tion, a continuous random-effects model was used to findstandard difference in means, SMD. There was a signifi-
cant difference in scores between males and females:
Hedges’ g = 0.40, P <0.001, z = 3.36. This holds true even if
simple unweighted means are compared, though individ-
ual mean values are slightly reduced (Figure 3). A sugges-
tion of bimodality was observed for males and females.
However, previous observations of AQ scores indicate that
there is a normal distribution within the population; likely
8 10 12 14 16 18 20 22 24
Baron−Cohen et al., 2001
Bird, Catmur, Silani, Frith, & Frith, 2006
Dziobek et al., 2006
Golan, Baron−Cohen, Hill, & Golan, 2006
S. White, Hill, Winston, & Frith, 2006
Lombardo, Barnes, Wheelwright, & Baron−Cohen, 2007
Corden, Chilvers, & Skuse, 2008
Gowen, Stanley, & Miall, 2008
L. Crane, Goddard, & Pring, 2009a
L. Crane, Goddard, & Pring, 2009b
Towgood, Meuwese, Gilbert, Turner, & Burgess, 2009
Hall, Hutton, & Morgan, 2010
Kuhn et al., 2010
A. A. Marsh et al., 2010
Philip et al., 2010
Wheelwright et al., 2010
Harris & Lindell, 2011
L. E. Marsh & Hamilton, 2011
Palermo, Rivolta, Wilson, & Jeffery, 2011
Palermo, Willis, et al., 2011
Rojas et al., 2011
von dem Hagen et al., 2011
S. J. White, Coniston, Rogers, & Frith, 2011
Zwickel, White, Coniston, Senju, & Frith, 2011
Allison et al., 2012
Bakhtiari et al., 2012
F. D. C. C. Beacher et al., 2012
F. D. Beacher et al., 2012
Bejerot et al., 2012
Benson, Castelhano, Au−Yeung, & Rayner, 2012
L. Crane, Pring, Jukes, & Goddard, 2012
C.R. Damiano, Aloi, Treadway, Bodfish, & Dichter, 2012
De Andres−Garcia, Moya−Albiol, & Gonzalez−Bono, 2012
Dohn, Garza−Villarreal, Heaton, & Vuust, 2012
Kessler & Wang, 2012
Lachat, Hugueville, Lemar_chal, Conty, & George, 2012
Maras & Bowler, 2012
Norenzayan, Gervais, & Trzesniewski, 2012
Nummenmaa, Engell, von dem Hagen, Henson, & Calder, 2012
Webb et al., 2012
Berthoz, Lalanne, Crane, & Hill, 2013
Broadbent et al., 2013
Brown, Singel, Hepburn, & Rojas, 2013
Cook, Brewer, Shah, & Bird, 2013
L. . Crane, Lind, & Bowler, 2013
Eriksson, 2013
Gibbard et al., 2013
Haffey, Press, O'Connell, & Chakrabarti, 2013
Jackson et al., 2013
Kapp, Gillespie−Lynch, Sherman, & Hutman, 2013
Lai et al., 2013
S.E. Lind, Williams, Raber, Peel, & Bowler, 2013
Miller & Saygin, 2013
R L Moseley et al., 2013
Nicolaidis et al., 2013
Wilson et al., 2013
Bennett, Bolling, Anderson, Pelphrey, & Kaiser, 2014
Caldwell−Harris & Jordan, 2014
C.R Damiano et al., 2014
Egorova, Pulvermul_ler, & Shtyrov, 2014
Hadjikhani et al., 2014
Kadak et al., 2014
S.E. Lind, Williams, Bowler, & Peel, 2014
Mayer & Heaton, 2014
R.L. Moseley et al., 2014
Murray et al., 2014
Rogers et al., 2014)
Schwarzkopf, Anderson, de Haas, White, & Rees, 2014
Steeb et al., 2014
Tottenham et al., 2014
Williams, Jarrold, Grainger, & Lind, 2014
Figure 2 Individual study overall Autism-Spectrum Quotient (AQ) means for nonclinical populations. Bars indicate confidence intervals,
point size scaled to the number of individuals in each study. Studies are ordered chronologically. From 2001 to 2011, the unweighted mean AQ
score = 15.27 (SD = 1.73); from 2012 to 2014, m = 15.37 (SD = 2.12). Overall mean is indicated by the dotted line.
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ber of data points used in this calculation (10 studies per
group) or from the internal differences in study recruit-
ment paradigms.
After initial selection criteria were applied, N = 9;
[35,40,48,52,59,62,70,83,91]) studies were identified that
excluded any individuals who might have the BAP fromthe typical group [17]. Table 2 presents the descriptive
statistics for this set.
Quantitative characterization of the Autism-Spectrum
Quotient in a clinical sample
The 78 included studies were also examined for the pres-
ence of a matched clinical sample of individuals with a
Table 2 Descriptive statistics for selected articles
Nonclinical Samplea Nonclinical Sample - BAP excludedb Matched ASC Casesc
Malesd Femalese Overallf Malesd Femalese Overallf Malesd Femalese Overallf
Mean AQ 17.89 14.88 16.94 14.84 12.73 15.03 36.40 38.83 35.19
Range 11.4 to 19.0 10.4 to 17.4 11.6 to 20.0 11.7 to 18.3 10.4 to 17.0 11.9 to 17.6 28.0 to 40.1 31.9 to 42.5 27.6 to 41.1
SD Range 4.2 to 7.9 4.2 to 8.0 0.8 to 9.7 4.5 to 6.9 4.2 to 4.8 0.8 to 6.4 6.8 to 13.0 4.4 to 13.0 4.6 to 10.1
CI 16.7 to 19.1 13.3 to 16.5 16.4 to 17.4 7.0 to 22.7 4.9 to 20.6 13.0 to 17.1 33.1 to 39.7 36.3 to 41.4 34.5 to 35.9
N (studies) 10 10 72 3 3 7 6 6 39
N (participants) 872 1378 4931 77 74 174 363 298 1374
Nonclinical Samplea describes reports from nonclinical samples. Nonclinical Sample – BAP excludedb describes a subset of the previous sample, where it was
specified that individuals from the BAP had been excluded. Matched ASC Casesc describes reports from available matched autism spectrum cases. Statistics
calculated for all available reported data (see also Table 1). Malesd and Femalese refer to available data reported by sex, while Overallf refers to samples from
studies reporting undifferentiated or combined male and female score. AQ: Autism-Spectrum Quotient; ASC: Autism spectrum conditions; BAP: broader autism
phenotype; CI: confidence interval; N: number; SD: standard deviation.
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data from 1,963 individuals with ASC (Table 1). Descrip-
tive statistics for matched clinical cases are shown in
Table 2. Overall SD reported from included studies ranged
from 4.6 to 10.09. A pooled variance was calculated from
the scores (σ2 = 39.27), leading to a pooled standard devi-
ation of 6.27.
To compare the weighted mean AQ scores between
clinical and nonclinical groups, a continuous random-
effects model was used to find SMD. There was a signifi-
cant difference in scores between these groups: Hedges’
g = 2.86, P <0.0001, z = 26.42, confirming that AQ scores
are elevated in individuals with ASC. Contrasting with
the findings reported for nonclinical controls, the SMD
for males and females with ASC only reached a value of
0.33, which, while significant, indicates that males and
females with ASC do not effectively differ in autistic
traits as measured by the AQ; in fact, if anything, in this
sample, the trend is reversed so that females self-report











Figure 3 AQ distributions for nonclinical populations. (A) Kernel density
for nonclinical populations. AQ score on the x-axis and density on the y-axis.
(B) Box plot of mean AQ scores for all studies. Box width scaled to reflect theTrends in use of the Autism-Spectrum Quotient
In addition to reviewing the reported AQ scores, an effort
was made to qualitatively assess AQ usage for included
studies. Several trends were noted in administration and
reporting of the full-scale AQ for adults. The majority of
studies included in this review had recruited via newspaper
adverts, employment agencies, email, post, and flyers. In
many cases, the participants were also partially drawn from
continuously maintained participant databases and re-
search pools. There was also evidence of partial recruit-
ment through hospitals and universities (though, as stated,
studies were excluded where recruitment was exclusively
within an academic community). In a number of instances,
participants were recruited using publicly available online
survey tools such as Amazon Mechanical Turk (M-Turk)
and surveymonkey.com. Finally, several large studies were
made possible through the use of birth cohorts, including
the Raine Cohort (in Western Australia).
Few articles specified the precise inclusion and exclusion


















estimates for unweighted Autism-Spectrum Quotient (AQ) distributions
Male scores in blue, female scores in red, and combined scores in black.
number of studies included.
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thors did routinely specify that control participants did
not have a history of psychological or neurodevelopmental
conditions, articles rarely reported having also excluded
participants there was a family history of these. Studies
also rarely reported testing the psychometric properties of
the AQ or the normality of the distribution of AQ score.
For instance, the mean was only reported alongside me-
dian in one instance [54], and there was also only one in-
stance of a test for normality (Kolmogorov-Smirnov test
[83]). There were occasional reports of other psychomet-
ric properties of the AQ, such as Cronbach’s alpha, estab-
lishing good internal consistency of the AQ.
Conclusions
This is the first systematic review of the AQ, with several
findings emerging. First, the mean AQ score in a typical
sample drawn from a nonclinical population is approxi-
mately 17 (CI 16.4 to 17.4) (for those explicitly excluding
BAP, the mean is approximately 15 (CI 13.0-17.1)), with a
narrow confidence interval of one to two points. In
addition, the mean AQ score in individuals with ASC is
approximately 35, nearly 20 points above that found in
the general population. Second, control males and fe-
males have significantly different average AQ scores,
with males scoring higher, confirming earlier reports.
Third, from 2001 onwards, there is considerable fluctu-
ation in reported mean AQ scores, but scores have not
appreciably drifted in one direction or another within
the general population.
Several rationales were employed by researchers for
using the AQ. Many of the studies administered the AQ
not as a central variable correlated with the outcome
measure, but as an accessory measure for characterizing
the population or defining the experimental groups. Fur-
ther, a number of articles used the AQ as a proxy for
diagnosis, using the cut-off scores of either 32 or 26 to
exclude individuals either from the clinical or from the
nonclinical control group. (These articles were not in-
cluded in the final analysis). However, caution is recom-
mended when using the AQ in this way, as the AQ was
designed to be a descriptive, rather than a diagnostic,
measure of autistic traits. While, perhaps due to it being
freely available, easy to administer, and widely prece-
dented in the literature, the AQ is used as a screening
instrument (such as for patients referred to a diagnostic
clinic for a detailed assessment for ASC [93]), it has
been argued that the AQ does not have the sensitivity
and specificity for population screening with an eye to
diagnosis [94-96]. This follows logically from the fact
that the AQ is a brief self-report, reliant upon the indi-
viduals’ own self-awareness, and from the self-imposed
limitations of age (16+) and IQ (85+). As discussed in
the original publication, the AQ was developed from atheoretical understanding of autism, and therefore has not
necessarily undergone the rigorous psychometric evalu-
ation procedure that diagnostic screening tools must pass
for inclusion in clinical practice. A more conservative use
for the AQ is to segment the population into bands of
autism phenotypes (broad, medium and narrow) as in the
method of Wheelwright and colleagues [17], or as a de-
scriptive quantitative measure of autistic traits.
Strengths of the current review include the exhaustive
search criteria, especially the citation search for relevant
papers, followed by the rigorous selection process. In
addition, the total number of individuals (N = 8,897 clin-
ical cases and nonclinical controls) examined by this re-
view lends weight to the findings. The study was limited
by a risk of bias, at the outcome level, the selection level
and at the level of the review, though an effort was made
to mitigate possible disproportionate effect of means from
studies of varying samples through weighting by group
size. Limitations also exist in the review procedure, in that
each study included in the review was not judged for meth-
odological rigor, rather a holistic evaluation was made of
study methodology in an effort to report trends in items
such as recruitment strategies, participant inclusion, and
AQ data psychometric properties. Second, the number of
participants from each study was relatively small (mini-
mum N was set at 10); this is balanced by the large overall
sample size derived from summing all studies together.
More broadly, an ideal investigation of AQ score distribu-
tion would evaluate the raw data from each of the included
studies in order to also measure data spread and subscale
scores. However, this was not feasible for the current study.
Finally, not every included article verified that the control
group did not have ASC. Therefore there may have been
incomplete information on how representative the demo-
graphic distribution of the nonclinical sample that make
up this analysis may be.
We recommend that future researchers should think
carefully when planning a recruitment strategy, both for
nonclinical and clinical participants in order to be able to
clearly define participants in each group. Furthermore, the
field would greatly benefit if researchers better described
the control participants, stating the method of recruit-
ment in the methods. While healthy, typically-developing
participants are often taken for granted, the considerable
variability found in this review indicates that the method
of recruitment of a ‘true’ representative sample - either of
the general population or a specific patient group - may
significantly impact results. This could have implications
when examining group differences on dependent variables
if the groups have not been carefully defined, potentially
leading to attenuation of real groups differences.
We hope the current review holds value in the light of
the considerable range of research types under which
the AQ has been used. This dimensional approach to
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http://www.molecularautism.com/content/6/1/2quantifying autistic traits has been found to correlate
with a range of biological measures, including instances
of brain activity [97], brain structure [98], social percep-
tion using gaze-tracking [42], prenatal testosterone [99],
candidate genes and epigenetics [100]; clinical screening
[44] and autism genetic risk [17]. Thus, although it is a
self-report instrument, it correlates with a large number
of more objective measures, suggesting that autistic
traits are measurable aspect of personality, independent
of the Big 5 [101].
Future research might consider a similar investigation of
other versions of the AQ. Aside from the AQ-Adolescent
and -Child, widely-used cross-cultural and foreign-language
versions of the AQ exist, including translations into
Chinese [102], Dutch [103], French [104], Italian [105],
Japanese [106], Persian [107] and Polish [108], among
others. On the whole, the results from studies that utilize
these versions demonstrate analogous findings to those
found using English-language versions of the AQ; how-
ever, validation by systematic review has not been done.
In addition, a future study might attempt to undertake a
whole population survey of autistic traits using the AQ,
with more detailed information about the respondents
collected in order to make stronger claims about
generalizability. The underlying structure of taxa lead-
ing to AQ score distribution could be assessed using a
number of modelling solutions, including latent class,
taxometric, or factor mixture modelling. Perhaps, using
these techniques in a population sample of individuals
along the spectrum might help elucidate the apparent
gap between clinical and nonclinical scores, despite the
apparent continuity of autistic traits.Summary
The AQ continues to be a useful brief assessment instru-
ment for measuring autistic traits in adults of normal
intelligence. By determining the distribution of the AQ
in the nonclinical population, the AQ can now be used
more definitively to assess the extent to which other spe-
cialist populations exhibit autistic traits.
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